Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Catalytic | 3 | 2025 | 21 | 1.590 |
Why?
|
| Transgenes | 4 | 2025 | 187 | 1.160 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2023 | 113 | 1.080 |
Why?
|
| Dependovirus | 4 | 2025 | 709 | 1.080 |
Why?
|
| Morpholinos | 1 | 2025 | 52 | 0.910 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2025 | 28 | 0.900 |
Why?
|
| Cat Diseases | 1 | 2023 | 17 | 0.830 |
Why?
|
| Chiroptera | 1 | 2023 | 16 | 0.830 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1617 | 0.790 |
Why?
|
| Dog Diseases | 1 | 2023 | 60 | 0.790 |
Why?
|
| Receptors, Virus | 4 | 2020 | 73 | 0.760 |
Why?
|
| Biological Products | 1 | 2023 | 95 | 0.730 |
Why?
|
| Antibodies, Neutralizing | 3 | 2023 | 209 | 0.680 |
Why?
|
| Coronavirus | 1 | 2020 | 14 | 0.680 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 3 | 2013 | 5 | 0.610 |
Why?
|
| Symporters | 3 | 2013 | 17 | 0.600 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.580 |
Why?
|
| Riboswitch | 2 | 2018 | 2 | 0.560 |
Why?
|
| Genetic Therapy | 2 | 2025 | 791 | 0.530 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 39 | 0.530 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2017 | 99 | 0.500 |
Why?
|
| RNA | 1 | 2019 | 423 | 0.490 |
Why?
|
| Hepatocytes | 3 | 2013 | 218 | 0.470 |
Why?
|
| RNA, Messenger | 2 | 2018 | 1537 | 0.450 |
Why?
|
| Tupaia | 2 | 2013 | 2 | 0.440 |
Why?
|
| Animals | 14 | 2025 | 20663 | 0.410 |
Why?
|
| Hepadnaviridae | 1 | 2013 | 1 | 0.410 |
Why?
|
| Atelinae | 1 | 2013 | 1 | 0.410 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 878 | 0.400 |
Why?
|
| Mice | 7 | 2025 | 10843 | 0.350 |
Why?
|
| HEK293 Cells | 3 | 2021 | 622 | 0.300 |
Why?
|
| Virus Internalization | 4 | 2022 | 88 | 0.270 |
Why?
|
| Immune Evasion | 2 | 2023 | 68 | 0.240 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 2186 | 0.220 |
Why?
|
| Protein Binding | 4 | 2023 | 1603 | 0.220 |
Why?
|
| Mutation | 2 | 2023 | 2612 | 0.210 |
Why?
|
| Animals, Wild | 1 | 2023 | 13 | 0.210 |
Why?
|
| Horses | 1 | 2023 | 55 | 0.210 |
Why?
|
| Cats | 1 | 2023 | 87 | 0.210 |
Why?
|
| Hepatitis Delta Virus | 2 | 2012 | 3 | 0.200 |
Why?
|
| Hepatitis B virus | 2 | 2012 | 15 | 0.200 |
Why?
|
| Swine | 1 | 2023 | 376 | 0.190 |
Why?
|
| Humans | 15 | 2025 | 63444 | 0.190 |
Why?
|
| Dogs | 1 | 2023 | 325 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2157 | 0.190 |
Why?
|
| Mink | 1 | 2021 | 7 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 883 | 0.180 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2021 | 17 | 0.180 |
Why?
|
| Ligands | 3 | 2018 | 416 | 0.170 |
Why?
|
| Genetic Vectors | 2 | 2025 | 879 | 0.170 |
Why?
|
| Immunoglobulins | 1 | 2020 | 77 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 45 | 0.170 |
Why?
|
| Models, Chemical | 1 | 2020 | 139 | 0.160 |
Why?
|
| Cell Line | 3 | 2019 | 2040 | 0.150 |
Why?
|
| Genes, Reporter | 1 | 2019 | 257 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 702 | 0.150 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 144 | 0.140 |
Why?
|
| Clostridiales | 1 | 2017 | 8 | 0.140 |
Why?
|
| Hydrogen Bonding | 1 | 2016 | 129 | 0.130 |
Why?
|
| HIV-1 | 1 | 2021 | 721 | 0.120 |
Why?
|
| Nucleic Acid Conformation | 1 | 2016 | 239 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2013 | 1592 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 1991 | 0.120 |
Why?
|
| HeLa Cells | 1 | 2016 | 536 | 0.120 |
Why?
|
| RNA Interference | 1 | 2018 | 618 | 0.110 |
Why?
|
| HIV Infections | 1 | 2021 | 969 | 0.110 |
Why?
|
| Phlebovirus | 1 | 2013 | 2 | 0.110 |
Why?
|
| Binding Sites | 3 | 2021 | 905 | 0.100 |
Why?
|
| Myosin Heavy Chains | 1 | 2013 | 44 | 0.100 |
Why?
|
| Fever | 1 | 2013 | 66 | 0.100 |
Why?
|
| Hepadnaviridae Infections | 1 | 2013 | 1 | 0.100 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2013 | 18 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 54 | 0.100 |
Why?
|
| Protein Precursors | 1 | 2013 | 83 | 0.100 |
Why?
|
| Viral Envelope Proteins | 1 | 2012 | 103 | 0.090 |
Why?
|
| Immunization, Passive | 2 | 2022 | 105 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2018 | 687 | 0.090 |
Why?
|
| Female | 3 | 2021 | 32878 | 0.050 |
Why?
|
| Host Specificity | 1 | 2023 | 10 | 0.050 |
Why?
|
| Base Sequence | 2 | 2018 | 1331 | 0.050 |
Why?
|
| Male | 2 | 2021 | 29891 | 0.050 |
Why?
|
| Netherlands | 1 | 2021 | 24 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2021 | 18 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 1469 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 78 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 673 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 327 | 0.040 |
Why?
|
| Glycosylation | 1 | 2021 | 138 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 120 | 0.040 |
Why?
|
| HIV Antibodies | 1 | 2021 | 146 | 0.040 |
Why?
|
| Epitopes | 1 | 2021 | 290 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 149 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2021 | 117 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 619 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2022 | 324 | 0.040 |
Why?
|
| SELEX Aptamer Technique | 1 | 2018 | 3 | 0.040 |
Why?
|
| Aptamers, Nucleotide | 1 | 2018 | 22 | 0.040 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 29 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2018 | 94 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 1981 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2021 | 1149 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 3396 | 0.030 |
Why?
|
| DNA Primers | 1 | 2013 | 293 | 0.030 |
Why?
|
| Taurocholic Acid | 1 | 2012 | 1 | 0.020 |
Why?
|
| Tupaiidae | 1 | 2012 | 1 | 0.020 |
Why?
|
| Hepatitis D | 1 | 2012 | 2 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 235 | 0.020 |
Why?
|
| Photochemical Processes | 1 | 2012 | 17 | 0.020 |
Why?
|
| Hepatitis B | 1 | 2012 | 32 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2012 | 78 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 612 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 165 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 517 | 0.020 |
Why?
|
| Virion | 1 | 2012 | 121 | 0.020 |
Why?
|
| Biological Transport | 1 | 2012 | 291 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4694 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 840 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 574 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 855 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1654 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 921 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 14446 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 16825 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 17612 | 0.010 |
Why?
|